The Transfusion News email arrived in my inbox this morning:
Prophylactic Platelet Transfusions are Not Superior to Supportive Care for Dengue Patients with Thrombocytopenia
![]()
April 12, 2017
According to the World Health Organization, the incidence of dengue has increased 30-fold in the past 50 years, and over half of the world’s population is at risk of infection. Acute infection with dengue virus typically causes flu-like symptoms, but can also be associated with severe bleeding and thrombocytopenia. In order to determine if prophylactic [Read More]
According to the World Health Organization, the incidence of dengue has increased 30-fold in the past 50 years, and over half of the world’s population is at risk of infection. Acute infection with dengue virus typically causes flu-like symptoms, but can also be associated with severe bleeding and thrombocytopenia. In order to determine if prophylactic [Read More]
Current Evidence Suggests that Non-invasive Procedures are Best to Treat Fetal and Neonatal Alloimmune Thrombocytopenia
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) occurs when maternal alloantibodies develop against fetal platelet antigens. FNAIT may cause severe bleeding in the fetus, including intracranial hemorrhage and long-term disabilities, especially in subsequent pregnancies. Treatments for FNAIT include fetal blood sampling with intrauterine platelet transfusions, or maternal IV immunoglobulin transfusions with or without steroids. In order [Read More]
No comments:
Post a Comment